The 2020 decision by a divided Federal Circuit panel in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA regarding the extent to which an ANDA applicant who obtained regulatory approval.
Duane Morris LLP - District Court of Delaware Rules for Generic Pharma's Use of Skinny Label, but Permits Induced Infringement Suit to Proceed Against Insurer duanemorris.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from duanemorris.com Daily Mail and Mail on Sunday newspapers.
As we enter the second month of 2022, the old saying, "If at first you don't succeed, try, try again" and the famous line, "I'm not dead," from Monty Python and the Holy Grail, come to mind to describe two issues.
In one of the first district court opinions applying the Federal Circuit’s recent GSK decision on induced infringement in the context of label carve-outs, Judge Richard Andrews in the.